NOVARTIS AG News

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 26 04:36

6-K: Financial Report Q1 2024

Apr 23 18:09

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 19 04:33

SC 13D: Statement of acquisition of beneficial ownership by individuals-Novartis BidCo AG(11.56%),Novartis Pharma AG(11.56%), etc.

Apr 19 02:37

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 18 04:37

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 17 05:11

NOVARTIS AG | SC TO-T/A: Third party tender offer statement (Amendment)

Apr 16 03:50

NOVARTIS AG | SC TO-T: Third party tender offer statement

Apr 11 18:05

NOVARTIS AG | S-8 POS: S-8 POS

Feb 16 05:20

NOVARTIS AG | SC TO-C: Written communication relating to an issuer or third party tender offer

Feb 7 05:58

NOVARTIS AG | SC TO-C: Written communication relating to an issuer or third party tender offer

Feb 6 06:09

NOVARTIS AG | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.1%)

Feb 3 03:22

NOVARTIS AG | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 31 20:46

NOVARTIS AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 31 20:46

NOVARTIS AG | IRANNOTICE: IRANNOTICE

Jan 31 20:46

NOVARTIS AG | 20-F: Registration statement / Annual report / Transition report

Jan 31 20:41

NOVARTIS AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 8 13:00

NOVARTIS AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 11, 2023 19:05

NOVARTIS AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 6, 2023 09:19

NOVARTIS AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 28, 2023 19:10